NP / PA
Flores, Jessica
Flores, Jessica was paid $181K by Medicaid between Jul 2020 and Dec 2023, across 28 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 32% of everything it billed.
33Billing provider infoFLORES, JESSICA
RIO GRANDE CITY, TX 78582
RIO GRANDE CITY, TX 78582
33aNPI1912133992assigned 06/04/2009
33bProvider typePhysician Assistant
28Total paid$181K
24GClaims9,736
24DCodes billed28
24AFirst – last monthJul 2020 – Dec 2023
Compared with peers
Next to other Physician Assistant providers in Texas
Rank by total paid#62 of 161
Median peer was paid$43K
This provider vs. median4.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 680 | $18K | |
| 2021 | 5,174 | $114K | |
| 2022 | 3,675 | $48K | |
| 2023 | 207 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 2,132 | 1,968 | $57K |
| S8301 | Infection control supplies, not otherwise specified | 25% | 1,791 | 1,655 | $44K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 8.6% | 964 | 922 | $15K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.7% | 224 | 223 | $14K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 5.6% | 936 | 893 | $10K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.4% | 148 | 146 | $8K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.5% | 105 | 98 | $6K |
| 87809 | 3.4% | 479 | 460 | $6K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.3% | 602 | 291 | $6K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.6% | 689 | 287 | $5K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.1% | 27 | 26 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 342 | 331 | $2K |
16 more codes
| 99429 | <1% | 57 | $1K | |
| 90461 | <1% | 135 | $847.68 | |
| 87807 | <1% | 76 | $715.00 | |
| 81002 | <1% | 240 | $584.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 63 | $535.50 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 120 | $519.95 |
| 99000 | <1% | 66 | $385.27 | |
| 96161 | <1% | 20 | $33.22 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 40 | $21.91 |
| G9716 | Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason | <1% | 108 | $20.80 |
| 97802 | 0% | 108 | $0.00 | |
| S9451 | Exercise classes, non-physician provider, per session | 0% | 107 | $0.00 |
| 99406 | 0% | 76 | $0.00 | |
| 90686 | 0% | 52 | $0.00 | |
| 90672 | 0% | 15 | $0.00 | |
| 90648 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.